The Class of 2026 matched in 22 states across the country plus Washington D.C. The Class of 2026 matched in 21 different ...

Having a primary care physician reduces emergency department (ED) use among patients with end-stage kidney disease receiving dialysis, according to a study published in JAMA Network Open.

The GPS Mdx test is a 17-gene expression assay performed on prostate biopsy tissue that may identify signals of favorable vs unfavorable pathology.

Research backs up the trend around vasectomies spiking around March Madness. A 2017 study by health care system Athenahealth found urologists in its network performed 30% more vasectomies during the ...

Urinary stone disease is common, associated with substantial morbidity, has a high recurrence rate, and affects quality of life.1,2 Consumption of large volumes of fluids is a foundational strategy ...

Better continence, erectile function, but data on oncologic outcomes still 2 years away ...

Shenouda With me on today's call are Relmada Therapeutics, Inc.'s CEO, Dr. Sergio Traversa, who will briefly provide a summary of recent business highlights; Dr. Raj S. Pruthi, Relmada Therapeutics, ...

Still, the idea of recouping that lost time and expense, particularly by charging patients on Medicare or Medicaid, is "very ...

A non-ablative treatment for benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS) achieved durable ...

It's been another tough week for ASX healthcare but Morgans' Scott Power said there's been bright spots with Racura soaring on trial news.

The MarketWatch News Department was not involved in the creation of this content.-- Nadofaragene firadenovec-vncg received an NCCN Category 2A recommendation for patients with pap ...

As a potential biomarker of treatment response, ctDNA and utDNA analyses were performed before systemic therapy, at restaging, and for responders at the beginning of adjuvant nivolumab. ctDNA was ...